x

Hungary

FamiCord services are provided by Krio Intézet

Italy

FamiCord services are provided by FamiCord Italia

Latvia

FamiCord services are provided by Climes Sunu Banka

Luxemburg

FamiCord services are provided by Stemlab

Poland

FamiCord services are provided by Polski Bank Komórek Macierzystych

Portugal

FamiCord services are provided by Crioestaminal

Romania

FamiCord services are provided by Biogenis

Spain

FamiCord services are provided by Sevibe

Switzerland

FamiCord services are provided by Stemlab

Turkey

FamiCord services are provided by Yaşam Bankası

United Kingdom

FamiCord services are provided by Polski Bank Komórek Macierzystych

Albania

FamiCord services are provided by Biosave

Bosnia & Herzegovina

FamiCord services are provided by Biosave

Croatia

FamiCord services are provided by Biosave

Denmark

FamiCord services are provided by Cellaviva

Egypt

FamiCord services are provided by Cell Safe Bank

Kosovo

FamiCord services are provided by Biosave

Macedonia

FamiCord services are provided by Biosave

Montenegro

FamiCord services are provided by Biosave

Serbia

FamiCord services are provided by Biosave

Slovenia

FamiCord services are provided by Biosave

Sweden

FamiCord services are provided by Cellaviva

Ukraine

FamiCord services are provided by UBSK

News

The Polish Stem Cell Bankestablished cooperation with the biotechnology company Dystrogen Therapeutics. The agreement will enable joint research on chimeric cells and PBKM's production of ATMP stem cells based medicinal products - PBKM informed in a press release. Dystrogen Therapeutics SA was founded in 2017 by prof. Maria Siemionow and Dr. Kris Siemionow. "We are also connected with capital, because recently PBKM became a minority shareholder in Dystrogen" - said Jakub Baran, president of PBKM. Cell therapy with the use of chimeric cells (DEC) is to be used in all patients with Duchenne muscular dystrophy (DMD).